Nuzenio

Doses First Patient

Doses First Patient news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMT MetaVia’s DA-1726 Reaches Highest Doses in Phase 1 Study Ahead of 2026 Results - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:39:00 GMT Innovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer - BioPharma APACBioPharma APAC · Fri, 07 Aug 2026 01:05:55 GMT Structure Therapeutics posts $106.2M Q2 net loss, $1.34B cash; doses first patients in Phase 3 aleniglipron - TradingViewTradingView · Thu, 06 Aug 2026 20:35:29 GMT Theriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - Stock TitanStock Titan · Thu, 06 Aug 2026 12:11:14 GMT Theriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMT Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 12:00:00 GMT SystImmune doses first patient in Phase III trial for ES-SCLC - clinicaltrialsarena.comclinicaltrialsarena.com · Thu, 06 Aug 2026 10:25:17 GMT

Timeline

Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial Vanguard

Fri, 07 Aug 2026 06:39:00 GMTMetaVia’s DA-1726 Reaches Highest Doses in Phase 1 Study Ahead of 2026 Results - The Clinical Trial Vanguard

Fri, 07 Aug 2026 01:05:55 GMTInnovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer - BioPharma APAC

Thu, 06 Aug 2026 20:35:29 GMTStructure Therapeutics posts $106.2M Q2 net loss, $1.34B cash; doses first patients in Phase 3 aleniglipron - TradingView

Thu, 06 Aug 2026 12:11:14 GMTTheriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - Stock Titan

Thu, 06 Aug 2026 12:00:00 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock Titan

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Phase22 live mentions Trial15 live mentions The Clinical Trial8 live mentions First Patient6 live mentions Patient6 live mentions Results3 live mentions Clinical Trial Vanguard3 live mentions Stock Titan Stock3 live mentions Titan3 live mentions Patients3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Doses First Patient.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.